Management of priapism by therapeutic defibrination.
D000328:Adult; D001772:Blood Cell Count; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets; D001799:Blood Sedimentation; D005340:Fibrinogen / Q000032:analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D008297:Male; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000627:therapeutic use*; D010958:Plasminogen / Q000032:analysis; D011317:Priapism / Q000188:drug therapy*; D014688:Venoms
D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D014688:Venoms; D005340:Fibrinogen; D010958:Plasminogen; D010447:Peptide Hydrolases